(Q48100352)

English

Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

Ezequiel Alvarez

7

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

José R González-Juanatey

8

object named as

José R González-Juanatey

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

author name string

Sergio Raposeiras-Roubín

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

Bruno K Rodiño-Janeiro

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

Lilian Grigorian-Shamagian

3

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

María Moure-González

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

Ana Seoane-Blanco

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

Alfonso Varela-Román

6

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

publication date

3 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

12

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

10

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

1092-1100

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

Protein glycation, diabetes, and aging

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Soluble forms of RAGE in human diseases: clinical and therapeutical implications

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Clinical and prognostic value of advanced glycation end-products in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Advanced glycation endproducts in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Soluble Receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Role of inflammation and oxidative stress in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ117

21 January 2018

Identifiers

10.1093/EURJHF/HFQ117

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20685687

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48100352&oldid=1541559907"